GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosisJuly 7, 2023DiabetesHepatologyGastroenterology
Thirty-three percent of type 1 diabetes patients insulin free with stem cellsJuly 3, 2023DiabetesEndocrinology
WHO plans to declare common sweetener as possible carcinogenJune 30, 2023DiabetesObesityBusiness of MedicineGastroenterology
ADA: Screen all with type 2 diabetes for fatty liver diseaseJune 27, 2023DiabetesPreventive CareGastroenterology
SAFE algorithm detects liver disease in general populationJune 26, 2023HepatologyGastroenterologyDiabetes
‘Striking’ benefit of lipid lowering in primary preventionJune 26, 2023EndocrinologyCardiologyDiabetes
